GlassScriptPhysician profile
Barbara J Forseth
NPI 1114077161
$898.69
in general payments reported to CMS, 2019-2025
19 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $219 · 2021: $270 · 2023: $26.34 · 2024: $29.31 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $232.94 | 2019-2021 | |
| Abbott Laboratories | $134.32 | 2019-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $70.84 | 2019-2020 | |
| Amgen INC. | $64.31 | 2025 | Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $54.61 | 2019-2021 | |
| Nevro Corp. | $47.27 | 2021 | |
| Sanofi-Aventis U.S. LLC | $46.87 | 2025 | |
| Inspire Medical Systems, INC. | $45.33 | 2025 | Inspire |
| Novo Nordisk INC | $30.68 | 2020-2024 | Wegovy |
| Alkermes, INC. | $26.34 | 2023 | Aristada, Lybalvi |
| Depuy Synthes Sales INC. | $24.15 | 2020 | |
| Amarin Pharma, INC. | $23.76 | 2020 | |
| Esperion Therapeutics, INC. | $16.77 | 2021 | |
| Genentech USA, INC. | $15.08 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.47 | 2024 | Xifaxan |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.78 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.53 | 2020 | |
| Dexcom, INC. | $12.05 | 2020 | |
| Althera Pharmaceuticals LLC | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Forseth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.